Cargando…
Development of drug resistance in a murine mammary tumour.
The development of resistance to melphalan, cis-platinum and cyclophosphamide has been examined in the MT murine mammary carcinoma. A gradual decrease in therapeutic response was detected using growth delay and clonogenic cell survival during repeated drug treatment. A slow rate of resistance develo...
Autores principales: | McMillan, T. J., Stephens, T. C., Steel, G. G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1985
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977285/ https://www.ncbi.nlm.nih.gov/pubmed/4074637 |
Ejemplares similares
-
Clonal variation in the sensitivity of a murine mammary carcinoma to melphalan.
por: McMillan, T. J., et al.
Publicado: (1986) -
Rejection of murine mammary tumours in BALB/c mice.
por: Robidoux, S., et al.
Publicado: (1979) -
Metastasis of murine mammary tumour lines from the mammary gland and ectopic sites.
por: Unemori, E. N., et al.
Publicado: (1984) -
Therapy of murine mammary carcinoma metastasis with interferon gamma and MHC gene-transduced tumour cells.
por: Nanni, P., et al.
Publicado: (1996) -
Mechanisms of doxorubicin-induced drug resistance and drug resistant tumour growth in a murine breast tumour model
por: Christowitz, Claudia, et al.
Publicado: (2019)